Stay updated on MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial page.

Latest updates to the MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has undergone significant content removal regarding a clinical study on MM-141 for pancreatic cancer, including detailed descriptions of the study's purpose, methodology, and eligibility criteria. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference11%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check92 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
Stay in the know with updates to MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MM-141 Combo in Front-line Pancreatic Cancer Clinical Trial page.